{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:20:26Z","timestamp":1777987226400,"version":"3.51.4"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32GM81061"],"award-info":[{"award-number":["T32GM81061"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01NS124857"],"award-info":[{"award-number":["R01NS124857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["F31AG084303"],"award-info":[{"award-number":["F31AG084303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R33NS115102"],"award-info":[{"award-number":["R33NS115102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P51OD011106"],"award-info":[{"award-number":["P51OD011106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.brainresbull.2025.111297","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:01:26Z","timestamp":1741752086000},"page":"111297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson\u2019s disease: Insights from non-human primate studies"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-6641","authenticated-orcid":false,"given":"Marina E.","family":"Emborg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette M.","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"D\u2019Amour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia C.","family":"Colwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey C.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard J.","family":"Federoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jcp.24830","article-title":"Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease","volume":"230","author":"Acosta","year":"2015","journal-title":"J. Cell Physiol."},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111297_bib2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1182\/blood.2021011671","article-title":"Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice","volume":"139","author":"Adams","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib3","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1038\/s41467-022-30777-8","article-title":"Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery","volume":"13","author":"Alekseenko","year":"2022","journal-title":"Nat. Commun."},{"issue":"2 Suppl","key":"10.1016\/j.brainresbull.2025.111297_bib4","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1097\/01.tp.0000186390.10150.66","article-title":"Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection","volume":"80","author":"Allison","year":"2005","journal-title":"Transplantation"},{"issue":"7814","key":"10.1016\/j.brainresbull.2025.111297_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.brainresbull.2025.111297_bib6","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1242\/dev.097394","article-title":"How to make a midbrain dopaminergic neuron","volume":"142","author":"Arenas","year":"2015","journal-title":"Development"},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111297_bib7","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/ajt.13704","article-title":"Cell therapy for Parkinson's disease: a translational approach to assess the role of local and systemic immunosuppression","volume":"16","author":"Aron Badin","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/mds.28201","article-title":"Human fetal cell therapy in Huntington's disease: a randomized, multicenter, phase II trial","volume":"35","author":"Bachoud-L\u00e9vi","year":"2020","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib9","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1038\/s41467-019-12324-0","article-title":"MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates","volume":"10","author":"Badin","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/mds.28628","article-title":"Recent advances in the development of stem-cell-derived dopaminergic neuronal transplant therapies for Parkinson's disease","volume":"36","author":"Barbuti","year":"2021","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.stemcr.2022.11.019","article-title":"Lessons learnt, and still to learn, in first in human stem cell trials","volume":"18","author":"Barker","year":"2023","journal-title":"Stem Cell Rep."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111297_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease","volume":"25","author":"Barker","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"34","key":"10.1016\/j.brainresbull.2025.111297_bib14","doi-asserted-by":"crossref","first-page":"28865","DOI":"10.1074\/jbc.M112.363549","article-title":"Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid","volume":"287","author":"Bergfeld","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2025.111297_bib15","article-title":"Human natural killer receptors, co-receptors, and their ligands","volume":"14","author":"Biassoni","year":"2009","journal-title":"Curr. Protoc. Immunol., Chapter"},{"issue":"6307","key":"10.1016\/j.brainresbull.2025.111297_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/349329a0","article-title":"Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice","volume":"349","author":"Bix","year":"1991","journal-title":"Nature"},{"issue":"s2","key":"10.1016\/j.brainresbull.2025.111297_bib17","first-page":"S159","article-title":"Dopamine cell therapy: from cell replacement to circuitry repair","volume":"11","author":"Bj\u00f6rklund","year":"2021","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.brainresbull.2025.111297_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867015","article-title":"A comprehensive atlas of immunological differences between humans, mice, and non-human primates","volume":"13","author":"Bjornson-Hooper","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.brainresbull.2025.111297_bib19","unstructured":"BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson\u2019s Disease. (2021). Retrieved 07\/11 from \u3008https:\/\/bluerocktx.com\/bluerock-therapeutics-announces-first-patient-dosed-with-da01-in-phase-1-study-in-patients-with-advanced-parkinsons-disease\/\u3009."},{"key":"10.1016\/j.brainresbull.2025.111297_bib20","doi-asserted-by":"crossref","unstructured":"Borlongan, C.V., Isacson, O., & Sanberg, P.R. (2003). Immunosuppressant analogues in neuroprotection. Humana Press.","DOI":"10.1007\/978-1-59259-315-6"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14802\/jmd.22141","article-title":"Current status and future perspectives on stem cell-based therapies for Parkinson's disease","volume":"16","author":"Cha","year":"2023","journal-title":"J. Mov. Disord."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharm. Ther."},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.stem.2016.03.014","article-title":"Chemical control of grafted human PSC-derived neurons in a mouse model of Parkinson's disease","volume":"18","author":"Chen","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib24","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/brain\/awae142","article-title":"Parkinson's disease variant detection and disclosure: PD generation, a North American study","volume":"147","author":"Cook","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mcn.2010.06.017","article-title":"Differentiation of human ES and Parkinson\u2019s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid","volume":"45","author":"Cooper","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.0953-816x.2001.01473.x","article-title":"Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease","volume":"13","author":"Costantini","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/eji.201545497","article-title":"Innate immune memory: implications for host responses to damage-associated molecular patterns","volume":"46","author":"Cri\u0219an","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111297_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041120","article-title":"Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson\u2019s disease","volume":"7","author":"Daadi","year":"2012","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"28","key":"10.1016\/j.brainresbull.2025.111297_bib30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022091118","article-title":"Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice","volume":"118","author":"Deuse","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib31","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ilar\/ilx021","article-title":"Nonhuman primate models of neurodegenerative disorders","volume":"58","author":"Emborg","year":"2017","journal-title":"Ilar J."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3727\/096368908784423300","article-title":"GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys","volume":"17","author":"Emborg","year":"2008","journal-title":"Cell Transpl."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.celrep.2013.02.016","article-title":"Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain","volume":"3","author":"Emborg","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainresbull.2025.111297_bib35","first-page":"1","article-title":"Preclinical evaluation of transaxial intraputaminal trajectory for enhanced distribution of grafted cells in Parkinson\u2019s disease","author":"Emborg","year":"2024","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3727\/096368912X647144","article-title":"Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys","volume":"22","author":"Emborg","year":"2013","journal-title":"Cell Transpl."},{"issue":"23","key":"10.1016\/j.brainresbull.2025.111297_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11237030","article-title":"Clinical trials of stem cell therapy in Japan: the decade of progress under the National Program","volume":"11","author":"Enosawa","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13619-024-00191-0","article-title":"Continuous immunosuppression is required for suppressing immune responses to xenografts in non-human primate brains","volume":"13","author":"Feng","year":"2024","journal-title":"Cell Regen."},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111297_bib39","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1089\/ars.2009.2654","article-title":"Cell-based therapies for Parkinson's disease: past, present, and future","volume":"11","author":"Fitzpatrick","year":"2009","journal-title":"Antioxid. Redox Signal"},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111297_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib41","article-title":"Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance","volume":"4","author":"Gerace","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.3860","article-title":"HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells","volume":"35","author":"Gornalusse","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5042","key":"10.1016\/j.brainresbull.2025.111297_bib44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/2101240a0","article-title":"\"Fertile\" intestine nuclei","volume":"210","author":"Gurdon","year":"1966","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib45","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.celrep.2014.05.027","article-title":"Long-term health of dopaminergic neuron transplants in Parkinson's disease patients","volume":"7","author":"Hallett","year":"2014","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s Disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.brainresbull.2025.111297_bib47","doi-asserted-by":"crossref","unstructured":"Harding, J., Vintersten-Nagy, K., Shutova, M., Yang, H., Tang, J.K., Massumi, M., Izaidfar, M., Izadifar, Z., Zhang, P., Li, C., & Nagy, A.. (2019). Induction of long-term allogeneic cell acceptance and formation of immune privileged tissue in immunocompetent hosts. In. BioRxiv.","DOI":"10.1101\/716571"},{"key":"10.1016\/j.brainresbull.2025.111297_bib48","article-title":"Dopaminergic neuronal cell therapy for Parkinson\u2019s disease: results froma phase 1 study of bembaneprocel","author":"Henchcliffe","year":"2023","journal-title":"Mov. Disord. Soc. Annu. Meet."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reuma.2011.08.002","article-title":"Abatacept mechanism of action: concordance with its clinical profile","volume":"8","author":"Herrero-Beaumont","year":"2012","journal-title":"Reumatol. Clin."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41536-022-00221-y","article-title":"Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease","volume":"7","author":"Hiller","year":"2022","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.brainresbull.2025.111297_bib51","article-title":"Functional recovery from human induced pluripotent stem cell-derived dopamine neuron grafts is dependent on neurite outgrowth","author":"Hills","year":"2022","journal-title":"bioRxiv"},{"issue":"13-14","key":"10.1016\/j.brainresbull.2025.111297_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/scd.2023.0043","article-title":"Neurite outgrowth and gene expression profile correlate with efficacy of human induced pluripotent stem cell-derived dopamine neuron grafts","volume":"32","author":"Hills","year":"2023","journal-title":"Stem Cells Dev."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.stemcr.2017.07.020","article-title":"NK cell alloreactivity against KIR-ligand-mismatched HLA-haploidentical tissue derived from HLA haplotype-homozygous iPSCs","volume":"9","author":"Ichise","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib54","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/s41467-018-04011-3","article-title":"Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells","volume":"9","author":"Initiative","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib55","first-page":"373","article-title":"Basiliximab, mechanism of action and pharmacological properties","volume":"58","author":"Kapic","year":"2004","journal-title":"Medicinski Arhiv."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib56","doi-asserted-by":"crossref","first-page":"E544","DOI":"10.1111\/ctr.12016","article-title":"Variable magnitude of drug interaction between oral voriconazole and cyclosporine A in recipients of allogeneic hematopoietic stem cell transplantation","volume":"26","author":"Kikuchi","year":"2012","journal-title":"Clin. Transpl."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib57","first-page":"395","article-title":"Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease","volume":"1","author":"Kikuchi","year":"2011","journal-title":"J. Park. Dis."},{"issue":"7669","key":"10.1016\/j.brainresbull.2025.111297_bib58","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.stem.2021.01.005","article-title":"Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use","volume":"28","author":"Kim","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib60","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/mds.23770","article-title":"Risk of surgical delivery to deep nuclei: a meta-analysis","volume":"26","author":"Kimmelman","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2025.111297_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.omtm.2022.05.010","article-title":"Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application","volume":"26","author":"Kitano","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib62","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/cne.24081","article-title":"Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias","volume":"525","author":"Kordower","year":"2017","journal-title":"J. Comp. Neurol."},{"issue":"7378","key":"10.1016\/j.brainresbull.2025.111297_bib64","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"issue":"7371","key":"10.1016\/j.brainresbull.2025.111297_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nature10448","article-title":"Derivation of haploid embryonic stem cells from mouse embryos","volume":"479","author":"Leeb","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib66","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.kint.2021.04.044","article-title":"The emerging field of non-human leukocyte antigen antibodies in transplant medicine and beyond","volume":"100","author":"Lefaucheur","year":"2021","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.brainresbull.2025.111297_bib68","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainresbull.2025.111297_bib69","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1146\/annurev.neuro.24.1.869","article-title":"Early anterior\/posterior patterning of the midbrain and cerebellum","volume":"24","author":"Liu","year":"2001","journal-title":"Annu Rev. Neurosci."},{"issue":"23","key":"10.1016\/j.brainresbull.2025.111297_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232738","article-title":"Human embryonic stem cell-derived immature midbrain dopaminergic neurons transplanted in Parkinsonian Monkeys","volume":"12","author":"L\u00f3pez-Ornelas","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib71","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.10359","article-title":"Dyskinesia after fetal cell transplantation for parkinsonism: a PET study","volume":"52","author":"Ma","year":"2002","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2005.07.002","article-title":"Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats","volume":"21","author":"Maries","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib73","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI130272","article-title":"Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia","volume":"130","author":"Mathew","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/jlb\/lsac014","article-title":"Can we do that here? An analysis of US federal and state policies guiding human embryo and embryoid research","volume":"9","author":"Matthews","year":"2022","journal-title":"J. Law Biosci."},{"issue":"7653","key":"10.1016\/j.brainresbull.2025.111297_bib75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature22312","article-title":"Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations","volume":"545","author":"Merkle","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/ars.2010.3241","article-title":"Nonhuman primate models of human immunology","volume":"14","author":"Messaoudi","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.brainresbull.2025.111297_bib77","series-title":"StatPearls","article-title":"Azathioprine","author":"Mohammadi","year":"2025"},{"key":"10.1016\/j.brainresbull.2025.111297_bib78","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fnins.2019.00916","article-title":"Role of the immune system in the development of the central nervous system","volume":"13","author":"Morimoto","year":"2019","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib81","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/09546634.2011.590792","article-title":"Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology","volume":"23","author":"Muellenhoff","year":"2012","journal-title":"J. Dermatol. Treat."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111297_bib82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib83","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1177\/0271678X17710182","article-title":"Pro-inflammatory activation of primary microglia and macrophages increases 18\u2009kDa translocator protein expression in rodents but not humans","volume":"37","author":"Owen","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib84","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharm. Sci."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111297_bib85","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41422-024-00971-y","article-title":"Past, present, and future of cell replacement therapy for parkinson\u2019s disease: a novel emphasis on host immune responses","volume":"34","author":"Park","year":"2024","journal-title":"Cell Res."},{"issue":"7970","key":"10.1016\/j.brainresbull.2025.111297_bib86","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous treg cells in a cell therapy for Parkinson\u2019s disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2025.111297_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.853372","article-title":"Microvascular changes in Parkinson's disease- focus on the neurovascular unit","volume":"14","author":"Paul","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib88","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.brainresbull.2012.03.001","article-title":"The immunological challenges of cell transplantation for the treatment of Parkinson's disease","volume":"88","author":"Piquet","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.brainresbull.2025.111297_bib89","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/mds.23743","article-title":"Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin\/dopamine transporter ratio","volume":"26","author":"Politis","year":"2011","journal-title":"Mov. Disord."},{"issue":"22","key":"10.1016\/j.brainresbull.2025.111297_bib90","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1056\/NEJM198511283132221","article-title":"Skin cancer and cyclosporine therapy","volume":"313","author":"Price","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainresbull.2025.111297_bib91","series-title":"StatPearls","article-title":"Prednisone","author":"Puckett","year":"2025"},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111297_bib92","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/acn3.580","article-title":"Immunosuppressants and risk of Parkinson disease","volume":"5","author":"Racette","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib93","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/107385802237703","article-title":"Cellular replacement therapy for Parkinson's disease--where we are today?","volume":"8","author":"Redmond","year":"2002","journal-title":"Neuroscientist"},{"issue":"12","key":"10.1016\/j.brainresbull.2025.111297_bib94","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/s41592-023-02080-x","article-title":"In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain-striatum-cortex assembloids","volume":"20","author":"Reumann","year":"2023","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2565","article-title":"Regulation of innate immune responses in the brain","volume":"9","author":"Rivest","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.brainresbull.2025.111297_bib96","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present yourself! By MHC class I and MHC class II molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib97","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-024-03751-y","article-title":"Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson's disease models","volume":"15","author":"Rodr\u00edguez-P\u00e9rez","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib98","first-page":"137","article-title":"Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease","volume":"50","author":"Roitberg","year":"2002","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.stem.2013.11.014","article-title":"An effective approach to prevent immune rejection of human ESC-derived allografts","volume":"14","author":"Rong","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111297_bib100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41588-022-01147-3","article-title":"Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells","volume":"54","author":"Rouhani","year":"2022","journal-title":"Nat. Genet."},{"issue":"6 Suppl 3","key":"10.1016\/j.brainresbull.2025.111297_bib101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0049-0172(92)90009-3","article-title":"Mechanisms of action of cyclosporine and effects on connective tissues","volume":"21","author":"Russell","year":"1992","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.brainresbull.2025.111297_bib102","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fncel.2020.00250","article-title":"Is the immunological response a bottleneck for cell therapy in neurodegenerative diseases?","volume":"14","author":"Salado-Manzano","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111297_bib103","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1097-1129","article-title":"Testis-derived sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats","volume":"3","author":"Sanberg","year":"1997","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111297_bib104","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1634\/stemcells.2004-0172","article-title":"Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation","volume":"23","author":"Sanchez-Pernaute","year":"2005","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1089\/scd.2016.0268","article-title":"Strategies to enhance implantation and survival of stem cells after their injection in ischemic neural tissue","volume":"26","author":"Sandvig","year":"2017","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib106","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI131187","article-title":"Deep learning predicts function of live retinal pigment epithelium from quantitative microscopy","volume":"130","author":"Schaub","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresbull.2025.111297_bib107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2119\/molmed.2014.00188","article-title":"Human parthenogenetic embryonic stem cell-derived neural stem cells express HLA-G and show unique resistance to NK cell-mediated killing","volume":"21","author":"Schmitt","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.brainresbull.2025.111297_bib108","first-page":"2024","article-title":"Human stem cell-derived cardiomyocytes integrate into the heart of monkeys with right ventricular pressure overload","volume":"24","author":"Scholz","year":"2024","journal-title":"Cell Transplant."},{"issue":"20","key":"10.1016\/j.brainresbull.2025.111297_bib109","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOT.0000000000000606","article-title":"Biomarkers of rejection in kidney transplantation","volume":"24","author":"Singh","year":"2019","journal-title":"Curr. Opin. Organ Transpl."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib112","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1172\/JCI130767","article-title":"Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models","volume":"130","author":"Song","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib113","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3124","article-title":"Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model","volume":"33","author":"Steinbeck","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib114","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev. Infect. Dis."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib115","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/stem.1415","article-title":"Improved cell therapy protocols for Parkinson\u2019s disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons","volume":"31","author":"Sundberg","year":"2013","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib116","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1172\/JCI21137","article-title":"Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model","volume":"115","author":"Takagi","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresbull.2025.111297_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","article-title":"iPS cell-based therapy for Parkinson's disease: a Kyoto trial","volume":"13","author":"Takahashi","year":"2020","journal-title":"Regen. Ther."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib118","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.brainresbull.2025.111297_bib119","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-021-01257-1","article-title":"Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys","volume":"27","author":"Tao","year":"2021","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib121","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.stem.2023.03.017","article-title":"Advancing cell therapy for neurodegenerative diseases","volume":"30","author":"Temple","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib122","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (FK506): molecular and cellular mechanisms","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther. Drug Monit."},{"issue":"5391","key":"10.1016\/j.brainresbull.2025.111297_bib123","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111297_bib124","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3727\/096368916X692979","article-title":"Real-time intraoperative MRI intracerebral delivery of induced pluripotent stem cell-derived neurons","volume":"26","author":"Vermilyea","year":"2017","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stemcr.2017.04.033","article-title":"Cryopreservation maintains functionality of human iPSC dopamine neurons and rescues Parkinsonian phenotypes in vivo","volume":"9","author":"Wakeman","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib126","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3727\/096368913X664865","article-title":"Survival and integration of neurons derived from human embryonic stem cells in MPTP-lesioned primates","volume":"23","author":"Wakeman","year":"2014","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib127","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.stemcr.2018.05.010","article-title":"Human clinical-grade parthenogenetic ESC-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson's disease","volume":"11","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.brainresbull.2025.111297_bib128","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2015.12","article-title":"Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson\u2019s disease model","volume":"1","author":"Wang","year":"2015","journal-title":"Cell Discov."},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111297_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263021","article-title":"Microglia-secreted TNF-\u03b1 affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors","volume":"18","author":"Wenker","year":"2023","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111297_bib130","article-title":"Induced cognitive impairments reversed by grafts of neural precursors: a longitudinal study in a Macaque Model of Parkinson\u2019s Disease","volume":"9","author":"Wianny","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib131","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.stem.2020.08.014","article-title":"Human stem cell-derived neurons repair circuits and restore neural function","volume":"28","author":"Xiong","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib132","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.stemcr.2021.06.011","article-title":"Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology","volume":"16","author":"Xu","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib133","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1634\/stemcells.2007-0494","article-title":"Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats","volume":"26","author":"Yang","year":"2008","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111297_bib134","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneumeth.2008.08.027","article-title":"Striatal volume differences between non-human and human primates","volume":"176","author":"Yin","year":"2009","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medj.2022.10.003","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med"},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111297_bib136","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/mt.2013.105","article-title":"Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo","volume":"21","author":"Zaldumbide","year":"2013","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111297_bib137","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13550-020-00683-5","article-title":"18 F]FEPPA PET imaging for monitoring CD68-positive microglia\/macrophage neuroinflammation in nonhuman primates","volume":"10","author":"Zammit","year":"2020","journal-title":"EJNMMI Res."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111297_bib138","first-page":"2674","article-title":"Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity","volume":"47","author":"Zarcone","year":"1987","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111297_bib139","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/bjc.2014.423","article-title":"HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients","volume":"111","author":"Zhao","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111297_bib140","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjh.14622","article-title":"Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation","volume":"177","author":"Zhao","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"7350","key":"10.1016\/j.brainresbull.2025.111297_bib141","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2025.111297_bib142","article-title":"Neuroinflammation following traumatic brain injury: take it seriously or not","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:30:29Z","timestamp":1777984229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923025001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":142,"alternative-id":["S0361923025001091"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111297","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson\u2019s disease: Insights from non-human primate studies","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111297"}}